Céline Mascaux

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Immune evasion before tumour invasion in early lung squamous carcinogenesis

Céline Mascaux, Mihaela Angelova, Angela Vasaturo et al. · Nature · 2019 · 339 citations · Full text

Medicine, Immunology, Oncology +16

From Expert Review of Molecular Diagnostics

Céline Mascaux, Nir Peled, Kavita Garg et al. · 2010 · 283 citations

Medicine, Oncology, Cancer Screening +11

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)

Catherine Labbé, Michael Cabanero, Grzegorz Korpanty et al. · Lung Cancer · 2017 · 246 citations

Medicine, Molecular Genetics, Oncology +15

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

A. Jeanson, Pascale Tomasini, M. Souquet-Bressand et al. · Journal of Thoracic Oncology · 2019 · 229 citations · Full text

Life Sciences, Immunology, Oncology +14